CTA acts as a single point of contact for Sponsors and CROs for the centralised management and evaluation of study site feasibilities for First Time in Human studies through our broad network of experienced member sites.

Support is provided throughout the feasibility review process to facilitate communication and administration between the sponsor, CRO and member site.

Advice can be provided on suitable sites to take part in new trials based upon site capability and therapeutic areas of interest.

Contact Us to discuss your First Time in Human trial feasibilities.